Inveready presents new €25-million biotechnology fund

by Gemma Escarré,

Venture capital firm Inveready, a CataloniaBio & HealthTech member, is putting the finishing touches on a €25-million fund to invest in start-ups in the health and biotechnology arena. The fund will be launched in the coming weeks, according to information from Expansión

With this third vehicle coming soon, to be called Biotech III, Inveready will manage more than €175 million in investment. In total, they hope to build a portfolio of 20 to 25 companies, mainly in Spain. 

Photo: Sara Secall and Roger Piqué at the Inveready headquarters in Barcelona - © Expansión, Elena Ramón


To comment, please login or create an account